rs28937884
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_023067.4(FOXL2):c.251T>G(p.Ile84Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I84N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_023067.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXL2 | NM_023067.4 | c.251T>G | p.Ile84Ser | missense_variant | 1/1 | ENST00000648323.1 | NP_075555.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXL2 | ENST00000648323.1 | c.251T>G | p.Ile84Ser | missense_variant | 1/1 | NM_023067.4 | ENSP00000497217 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
FOXL2-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 15, 2023 | The FOXL2 c.251T>G variant is predicted to result in the amino acid substitution p.Ile84Ser. This variant has been reported as segregating with disease in a six generation kindred with blepharophimosis ptosis epicanthus inversus syndrome type I (Dollfus et al. 2003. PubMed ID: 12630957). Functional studies have shown that the p.Ile84Ser substitution within the FOXL2 protein causes aggregation and decreases the transcription activity, leading to a decrease in the cellular functions of apoptosis and antiproliferation (Dipietromaria et al. 2009. PubMed ID: 19515849; Kim et al. 2013. PubMed ID: 24240106). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. An alternate substitution of this amino acid (p.Ile84Asn) has also been reported in individuals with BPES (Beysen et al. 2008. PubMed ID: 18642388 ). Given the evidence, we interpret c.251T>G (p.Ile84Ser) as pathogenic. - |
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE I Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Feb 01, 2003 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at